دورية أكاديمية

Clinical and Radiographic Response With Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma.

التفاصيل البيبلوغرافية
العنوان: Clinical and Radiographic Response With Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma.
المؤلفون: Kaye, Frederic J., Ivey, Alison M., Drane, Walter E., Mendenhall, William M., Allan, Robert W.
المصدر: JNCI: Journal of the National Cancer Institute; Dec2014, Vol. 107 Issue 1, p1-1, 1p
مصطلحات موضوعية: AFRICAN American men, AMELOBLASTOMA, MANDIBLE, ORAL drug administration, FLUORODEOXYGLUCOSE F18, DISEASES
مستخلص: The article focuses on a study involving a 40-year-old African American male diagnosed with stage 4 metastatic ameloblastoma of the left mandible while the presence of a BRAF V600E mutation was detected and a cancer gene profile was obtained. Topics discussed include effects of GlaxoSmithKline oral drugs dabrafenib and trametinib, and fluorodeoxyglucose (FDG) activity.
قاعدة البيانات: Complementary Index
الوصف
تدمد:00278874
DOI:10.1093/jnci/dju378